NSE ScannerComparison · NSE · data 2026-11-01
Beta Drugs Ltd. vs Indoco Remedies Limited
In plain words
Size: Beta Drugs Ltd. is about 1 times the market value of Indoco Remedies Limited.
Valuation (P/E): Indoco Remedies Limited 60.1 vs Beta Drugs Ltd. 36.9.
Return on equity: Beta Drugs Ltd. 18.8% vs Indoco Remedies Limited -9.7%.
Debt to equity: Indoco Remedies Limited 1.15 vs Beta Drugs Ltd. 0.62.
Differences in the numbers, not a recommendation of either stock.
Side by side
| BETA | INDOCO | |
|---|---|---|
| Price | ₹1,798.4 | ₹208.3 |
| Market cap | ₹2,000 cr | ₹1,923 cr |
| P/E | 36.9 | 60.1 |
| P/B | 4.6 | 1.9 |
| ROE | 18.8% | -9.7% |
| ROCE | 16.6% | -2.0% |
| Debt / equity | 0.62 | 1.15 |
| Operating margin | 16.7% | 1.8% |
| Dividend yield | 0.00% | 0.10% |
| Sales growth, 3 years (yearly) | 19.2% | 3.0% |
| Profit growth, 3 years (yearly) | 10.5% | — |
| 1-year return | -4.8% | -25.0% |
| Revenue, last 12 months | ₹444 cr | ₹1,909 cr |
| Net profit, last 12 months | ₹52 cr | ₹32 cr |
| Latest quarter | Sept 2026 | Sept 2026 |
| Quarter net profit | ₹20 cr | ₹18 cr |
| Quarter profit vs a year earlier | — | — |
| Promoter holding | 58.91% | 58.92% |
| Health check | Strong (6.5/10) | Weak (2.5/10) |
Common questions
Which has a higher P/E, Beta Drugs Ltd. or Indoco Remedies Limited?
Indoco Remedies Limited trades at the higher P/E (60.1 against 36.9). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Beta Drugs Ltd. (18.8% against -9.7%).
Which carries more debt?
Indoco Remedies Limited has the higher debt-to-equity ratio (1.15 against 0.62).